Insider: McShane Geri-Michelle VP, CAO - Xylem Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 2,957 | 0 | 2,957 |
| Value | $418,267.65 | $0.00 | $418,267.65 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/05/2025 | DDS | 1,000 | Direct | COM | $139.96 | $139,962.00 | 2,957 |
| 03/07/2025 | DDS | 4,119 | Direct | COM | $128.18 | $527,977.95 | 3,950 |
| 06/10/2024 | DDS | 2,278 | Direct | COM | $138.63 | $315,799.14 | 3,536 |
| 02/20/2024 | DDS | 1,000 | Direct | COM | $122.89 | $122,890.00 | 2,935 |
| 09/28/2020 | DDS | 1,095 | Direct | COM | $84.21 | $92,209.95 | 2,205 |
| 09/28/2020 | DDS | 419 | Direct | COM | $84.21 | $35,283.99 | 1,786 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research